Zdrowie i gospodarka · 21/01/2011
FDA Requests Public Comment on Proposed Collection of Information for Orphan Drugs
The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to orphan drugs, as outlined in the Orphan Drug Act and a joint application form with the European Medicines Agency (EMA)
Source: Federal Register — Health and Human ServicesOpen original release →